Literature DB >> 25422212

Clinicopathological characteristics and prognosis of patients according to recurrence time after curative resection for colorectal cancer.

Oktay Bozkurt1, Mevlude Inanc, Esma Turkmen, Halit Karaca, Veli Berk, Ayse Ocak Duran, Ersin Ozaslan, Mahmut Ucar, Ilhan Hacibekiroglu, Baki Eker, Osman Baspinar, Metin Ozkan.   

Abstract

PURPOSE: To investigate clinicopathological features in patients with recurrent colorectal cancer within 1 year and more than 1 year after curative resection.
MATERIALS AND METHODS: We retrospectively evaluated 103 patients with disease recurrence before versus after 1 year of resection. Thirty-two patients (31%) were diagnosed with recurrence less than 1 year after curative resection for colorectal cancer (early recurrence) and 71 (69%) after more than 1 year (non-early recurrence).
RESULTS: The early recurrence group displayed a significantly lower overall survival rate for both colon cancer (p=0, 01) and rectal cancer (p<0.001). Inadequate lymph node dissection was a significant predictor for early relapse. There were no statistically significant differences in clinicopathological variables such as age, sex, primary tumor localization, stage, depth of invasion, lymphovascular invasion and perineural invasion between the early and non-early recurrence groups. However, a K-ras mutation subgroup was significantly associated with early recurrence (p<0.001).
CONCLUSIONS: Poor survival is associated with early recurrence for patients undergoing resection for non-metastatic colorectal cancer, as well as K-ras mutation.

Entities:  

Mesh:

Year:  2014        PMID: 25422212     DOI: 10.7314/apjcp.2014.15.21.9277

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Low preoperative psoas muscle mass index is a risk factor for distal cholangiocarcinoma recurrence after pancreatoduodenectomy: a retrospective analysis.

Authors:  Saori Umezawa; Shinjiro Kobayashi; Takehito Otsubo
Journal:  World J Surg Oncol       Date:  2022-06-02       Impact factor: 3.253

2.  Molecular correlates and prognostic value of tmTNF-α expression in colorectal cancer of 5-Fluorouracil-Based Adjuvant Therapy.

Authors:  Xiaogai Li; Shihai Wang; HuiJun Ren; Junfen Ma; Xiaoxu Sun; Nan Li; Cailin Liu; Kaida Huang; Min Xu; Liang Ming
Journal:  Cancer Biol Ther       Date:  2016-06-02       Impact factor: 4.742

3.  Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis.

Authors:  Yali Hu; Kunpeng Zhang; Xingyao Zhu; Xiuyan Zheng; Chao Wang; Xiao Niu; Teng Jiang; Xinhua Ji; Weilin Zhao; Lijuan Pang; Yan Qi; Feng Li; Li Li; Zhiping Xu; Wenyi Gu; Hong Zou
Journal:  Int J Nanomedicine       Date:  2021-03-15

4.  Long-Term Outcomes of Radical Surgery for Transverse Colon Cancer Staged from I to IIIC.

Authors:  Yaofei Jiang; Zhenhong Zou; Zulei Zhang; Yi Zhang; Yuting Sun; Bo Liang
Journal:  Cancer Manag Res       Date:  2020-12-22       Impact factor: 3.989

5.  Predictive Nomogram for the Prediction of Early Recurrence of Colorectal Cancer.

Authors:  Shangjun Tang; Yongjun Chen; Shan Tian; Yumei Wang
Journal:  Int J Gen Med       Date:  2021-08-26

6.  The Effect of Liposomal Diallyl Disulfide and Oxaliplatin on Proliferation of Colorectal Cancer Cells: In Vitro and In Silico Analysis.

Authors:  Faris Alrumaihi; Masood Alam Khan; Ali Yousif Babiker; Mohammed Alsaweed; Faizul Azam; Khaled S Allemailem; Ahmad A Almatroudi; Syed Rizwan Ahamad; Naif AlSuhaymi; Mahdi H Alsugoor; Ahmed N Algefary; Arif Khan
Journal:  Pharmaceutics       Date:  2022-01-20       Impact factor: 6.321

7.  Lipid-Based Nanoparticle Formulation of Diallyl Trisulfide Chemosensitizes the Growth Inhibitory Activity of Doxorubicin in Colorectal Cancer Model: A Novel In Vitro, In Vivo and In Silico Analysis.

Authors:  Faris Alrumaihi; Masood Alam Khan; Ali Yousif Babiker; Mohammed Alsaweed; Faizul Azam; Khaled S Allemailem; Ahmad A Almatroudi; Syed Rizwan Ahamad; Mahdi H Alsugoor; Khloud Nawaf Alharbi; Nahlah Makki Almansour; Arif Khan
Journal:  Molecules       Date:  2022-03-28       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.